Time: 2024-07-24
Good morning , everyone , and welcome to another working week . We hope the weekend respite was relaxing and invigorating , because that oh - so predictable routine of online meetings , phone calls , and deadlines has returned . But what can you do ? The world , such as it is , continues to spin . So to nudge it in a better direction , we are brewing cups of stimulation . Our choice today is hazelnut mocha . Please feel free to join us . Meanwhile , here are a few tidbits for you to chew on as you start the day , which we hope is meaningful and productive . Best of luck and , as always , do keep in touch .
Democratic U.S. Senate aides will meet with Novo Nordisk executives on Tuesday to discuss fallout from its decision to stop selling one of its long - acting insulins in the country , Reuters reports . Novo Nordisk will meet with aides for senators Jeanne Shaheen , Raphael Warnock , and Elizabeth Warren . In April , the lawmakers wrote to the company expressing alarm at its decision , announced in November , that it would permanently discontinue Levemir by the end of 2024 . Novo said it has given patients enough time to switch to other options , but is unaware of plans for drugmakers to produce a biosimilar version of the insulin , although Novo would not assert any patent against such a version.
European health authorities cautioned that patients undergoing surgery should be warned of a risk of anesthesia complications if they are being treated with diabetes and weight loss drugs from Novo Nordisk and Eli Lilly , Bloomberg News notes . The safety committee of the European Medicines Agency advised patients treated with GLP-1 drugs to inform their doctor before undergoing surgeries with general anesthesia or deep sedation and said product information will be updated accordingly . There is a biologically plausible risk of aspiration of stomach contents for patients under anesthesia and taking such medication , the agency said , even though it did n't find a causal association.
Democratic U.S. Senate aides will meet with Novo Nordisk executives to discuss the company 's decision to halt the sale of one of its long - acting insulins in the country . Novo Nordisk will engage with aides for senators Jeanne Shaheen , Raphael Warnock , and Elizabeth Warren , who expressed alarm at the decision to discontinue Levemir by the end of 2024 . The company stated that patients have been given sufficient time to switch to alternative options , but questions remain about the production of a biosimilar version of the insulin .
Patients undergoing surgery while being treated with diabetes and weight loss drugs from Novo Nordisk and Eli Lilly should be cautious of anesthesia complications , according to European health authorities . The safety committee of the European Medicines Agency highlighted the need for patients on GLP-1 drugs to inform their doctors before undergoing surgeries with general anesthesia or deep sedation . Precautions are being taken to update product information to address the possible risk of aspiration of stomach contents for patients under anesthesia and taking these medications.
Business
